July 7, 2025 MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion
July 7, 2025 MedRhythms Appoints Larry Jasinski as Chief Executive Officer to Lead Next Phase of Growth and Commercial Expansion
March 6, 2025 MedRhythms Announces FDA Class II Listing for Movive™ to Support Gait Rehabilitation and Motor Function for Parkinson’s Disease
March 6, 2025 MedRhythms Announces FDA Class II Listing for Movive™ to Support Gait Rehabilitation and Motor Function for Parkinson’s Disease
August 11, 2022 MedTech Insight MedRhythms On First-To-Market Track With Prescription Music Therapy For Chronic Stroke
August 11, 2022 MedTech Insight MedRhythms On First-To-Market Track With Prescription Music Therapy For Chronic Stroke
March 20, 2022 EDM UMG and MedRhythms Partner to Treat Neurological Disorders with “Prescription Music”
March 20, 2022 EDM UMG and MedRhythms Partner to Treat Neurological Disorders with “Prescription Music”
October 31, 2022 Hope Post-Stroke: Stories of Resilience and Determination from the Stroke Survivor Community
October 31, 2022 Hope Post-Stroke: Stories of Resilience and Determination from the Stroke Survivor Community
